PortfoliosLab logoPortfoliosLab logo
TER vs. AZN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TER vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teradyne, Inc. (TER) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TER achieves a 93.73% return, which is significantly higher than AZN's 0.81% return. Over the past 10 years, TER has outperformed AZN with an annualized return of 34.87%, while AZN has yielded a comparatively lower 15.85% annualized return.


TER

1D
4.68%
1M
4.19%
YTD
93.73%
6M
84.73%
1Y
340.75%
3Y*
53.39%
5Y*
25.10%
10Y*
34.87%

AZN

1D
-2.37%
1M
-0.71%
YTD
0.81%
6M
1.53%
1Y
28.04%
3Y*
9.54%
5Y*
12.08%
10Y*
15.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TER vs. AZN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TER
Teradyne, Inc.
93.73%54.39%16.51%24.78%-46.35%36.81%76.73%118.93%-24.37%66.16%
AZN
AstraZeneca PLC
0.81%43.30%-0.62%1.44%19.14%19.66%3.12%35.68%13.86%33.10%

Correlation

The correlation between TER and AZN is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since May 18, 1993

0.22

Fundamentals

Market Cap

TER:

$59.06B

AZN:

$283.40B

EPS

TER:

$5.38

AZN:

$6.66

PE Ratio

TER:

69.70

AZN:

27.27

PS Ratio

TER:

15.72

AZN:

4.69

PB Ratio

TER:

18.79

AZN:

5.99

Total Revenue (TTM)

TER:

$3.79B

AZN:

$60.44B

Gross Profit (TTM)

TER:

$2.23B

AZN:

$49.37B

EBITDA (TTM)

TER:

$1.11B

AZN:

$20.47B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TER vs. AZN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TER
TER Risk / Return Rank: 9898
Overall Rank
TER Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
TER Sortino Ratio Rank: 9696
Sortino Ratio Rank
TER Omega Ratio Rank: 9696
Omega Ratio Rank
TER Calmar Ratio Rank: 9898
Calmar Ratio Rank
TER Martin Ratio Rank: 9999
Martin Ratio Rank

AZN
AZN Risk / Return Rank: 7373
Overall Rank
AZN Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
AZN Sortino Ratio Rank: 7373
Sortino Ratio Rank
AZN Omega Ratio Rank: 6969
Omega Ratio Rank
AZN Calmar Ratio Rank: 7474
Calmar Ratio Rank
AZN Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TER vs. AZN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Teradyne, Inc. (TER) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TERAZNDifference
Sharpe ratioReturn per unit of total volatility

+4.08

Sortino ratioReturn per unit of downside risk

+2.52

Omega ratioGain probability vs. loss probability

1.63

1.21

+0.41

Calmar ratioReturn relative to maximum drawdown

12.85

1.83

+11.01

Martin ratioReturn relative to average drawdown

46.52

4.90

+41.62

TER vs. AZN - Sharpe Ratio Comparison

The current TER Sharpe Ratio is 5.19, which is higher than the AZN Sharpe Ratio of 1.11. The chart below compares the historical Sharpe Ratios of TER and AZN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TERAZNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

5.19

1.11

+4.08

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.51

0.51

0.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.78

0.64

+0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.49

-0.27

Drawdowns

TER vs. AZN - Drawdown Comparison

The maximum TER drawdown since its inception was -97.30%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for TER and AZN.


Loading charts...

Drawdown Indicators


TERAZNDifference

Max Drawdown

Largest peak-to-trough decline

-97.30%

-48.94%

-48.36%

Max Drawdown (1Y)

Largest decline over 1 year

-26.73%

-15.43%

-11.30%

Max Drawdown (3Y)

Largest decline over 3 years

-58.18%

-27.87%

-30.31%

Max Drawdown (5Y)

Largest decline over 5 years

-59.12%

-27.87%

-31.25%

Max Drawdown (10Y)

Largest decline over 10 years

-59.12%

-27.87%

-31.25%

Current Drawdown

Current decline from peak

-10.34%

-12.90%

+2.56%

Average Drawdown

Average peak-to-trough decline

-58.69%

-11.37%

-47.32%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.37%

5.75%

+1.62%

Volatility

TER vs. AZN - Volatility Comparison

Teradyne, Inc. (TER) has a higher volatility of 21.89% compared to AstraZeneca PLC (AZN) at 7.42%. This indicates that TER's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TERAZNDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.89%

7.42%

+14.47%

Volatility (6M)

Calculated over the trailing 6-month period

51.74%

17.47%

+34.27%

Volatility (1Y)

Calculated over the trailing 1-year period

66.25%

25.55%

+40.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

49.92%

24.02%

+25.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.15%

24.94%

+20.21%

Dividends

TER vs. AZN - Dividend Comparison

TER's dividend yield for the trailing twelve months is around 0.13%, less than AZN's 2.93% yield.


PositionTTM20252024202320222021202020192018201720162015
AZN
AstraZeneca PLC
2.93%1.70%2.27%2.15%2.12%2.35%2.80%2.81%3.69%3.95%5.01%4.06%
TER
Teradyne, Inc.
0.13%0.25%0.38%0.41%0.50%0.24%0.33%0.53%1.15%0.67%0.94%1.16%

Financials

TER vs. AZN - Financials Comparison

This section allows you to compare key financial metrics between Teradyne, Inc. and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
1.28B
15.29B
(TER) Total Revenue
(AZN) Total Revenue
Values in USD except per share items

TER vs. AZN - Profitability Comparison

The chart below illustrates the profitability comparison between Teradyne, Inc. and AstraZeneca PLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20222023202420252026
60.9%
82.5%
Portfolio components
TER - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teradyne, Inc. reported a gross profit of 780.95M and revenue of 1.28B. Therefore, the gross margin over that period was 60.9%.

AZN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.

TER - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teradyne, Inc. reported an operating income of 473.00M and revenue of 1.28B, resulting in an operating margin of 36.9%.

AZN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.

TER - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teradyne, Inc. reported a net income of 398.91M and revenue of 1.28B, resulting in a net margin of 31.1%.

AZN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.


Frequently Asked Questions


TER and AZN have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TER has higher volatility (21.89%) compared to AZN (7.42%). In terms of maximum drawdown, TER dropped -97.30% vs AZN's -48.94%.

TER currently has the higher Sharpe Ratio (5.19 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TER and AZN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer